Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Voltage-gated chloride channels (ClC family) are integral membrane proteins that facilitate the selective passage of chloride ions across cellular membranes in response to changes in membrane potential. In gliomas, particularly malignant forms, these channels—most notably ClC-2 and ClC-3—are upregulated and play a critical role in tumor cell physiology. They mediate cell volume regulation, rapid changes in cell size/shape during division or migration, and enhance invasive migration. Their upregulation correlates with higher glioma grade and poorer patient survival, making them attractive targets for therapeutic intervention.
Blockade or genetic suppression of chloride channel activity
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Voltage-Gated Chloride Channel Protein (Glioma-Specific) (ClC).